DCOY Decoy Therapeutics Inc.

P/E 0.0973
Forward P/E --
Price/Sales 12.99
Beta 0.644
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 DCOY is trading 12.4% down today as it extends pullback from financing-driven rally

DCOY is trading at $6.30 (12.4% down) as the stock extends a sharp pullback from its June 29 surge driven by a private placement financing of up to $21...

🔴 DCOY is trading 5.4% down today on profit-taking after private placement surge

DCOY is trading at $6.80 (5.4% down) in after-hours as the stock extends a pullback following a sharp reversal from its June 29 private placement-driven...

🔴 DCOY is trading 28.4% down today on profit-taking after private placement surge

DCOY is trading at $6.87, down 28.4% today as the stock undergoes a sharp reversal following yesterday’s private placement-fueled spike. • Shares had soared...

🔴 DCOY is trading 18.35% down today on profit-taking after a private placement-driven surge

DCOY is trading at $7.83, down 18.35% today as the stock undergoes normalization and profit-taking following a massive rally. • Shares of Decoy Therapeutics...

🔴 DCOY is trading 10.8% down today on profit-taking after a major private placement rally

DCOY is trading at $8.55 (down 10.8%) as the stock undergoes a period of normalization following a massive triple-digit surge earlier in the session. • Decoy...

🟢 DCOY is trading 144.84% up today after announcing a $3.5M private placement to fund clinical trials

DCOY is trading at $13.51 (144.84%) up today after Decoy Therapeutics announced a $3.5 million private placement to advance its lead asset into clinical...

Decoy Therapeutics to Raise $3.5M in Private Placement to Fund Clinical Trials

Decoy Therapeutics to Raise $3.5M in Private Placement to Fund Clinical Trials

Decoy Therapeutics Inc. has entered into a securities purchase agreement with an institutional investor for a private placement expected to raise approximately...

Decoy Therapeutics Doubles in Pre-Market After SEC Clears Its Offering — But Can a $3 Million Biotech Sustain a 124% Rally on Hope Alone?

Decoy Therapeutics Doubles in Pre-Market After SEC Clears Its Offering — But Can a $3 Million Biotech Sustain a 124% Rally on Hope Alone?

Shares of Decoy Therapeutics (DCOY) surged +124% to $12.38 in pre-market trading Monday, an extraordinary reversal for a stock that closed Friday at just $5.52...

🟢 DCOY is trading 124.3% up today as its $3.5M private placement financing is set to close

Decoy Therapeutics (DCOY) is trading at $12.38 (+124.3%) in pre-market, rebounding sharply from its prior close of $5.52 following news of a significant...

🔴 DCOY is trading 6.9% down today after SEC clears path for IPO and securities offering

DCOY is trading 6.9% down at $5.50 after the SEC declared its S-1 registration effective, clearing the path for Decoy Therapeutics’ planned IPO and related...

🔴 DCOY is trading 7.2% down today as SEC effectiveness clears path for IPO

DCOY is trading 7.2% down at $5.49 after the company received SEC effectiveness for its S-1 registration, clearing the way for its planned IPO and related...

Decoy Therapeutics Clears SEC Hurdle, Paving Way for AI Biotech IPO

Decoy Therapeutics Clears SEC Hurdle, Paving Way for AI Biotech IPO

Decoy Therapeutics Inc. received a notice of effectiveness from the U.S. Securities and Exchange Commission (SEC) for its S-1 registration statement. This...

🟢 DCOY is trading 8.5% up today in a rebound following a weak session with no clear catalyst

DCOY is trading at $6.51 (+8.50%) in pre-market action, rebounding from a weak prior session despite a lack of fresh company-specific news, earnings, or...

🔴 DCOY is trading 5.9% down today on light, catalyst-free trading

DCOY is trading at $5.92 (-5.90%) in pre-market action on light, catalyst-free trading following a prior session close of $6.30. • No company-specific...

🟢 Decoy Therapeutics Inc. is trading 6.3% up today with no clear catalyst

Decoy Therapeutics Inc. is trading 6.3% up at $6.45 on light, catalyst-free trading so far today. • No fresh company-specific news, filings, analyst calls, or...

🟢 Decoy Therapeutics Inc. is trading 2.4% up today as it rebounds from dilution-driven selloff

Decoy Therapeutics Inc. is trading 2.4% up today at $6.09 as it rebounds from a recent dilution-driven selloff. • The stock faced pressure earlier this week...

🟢 Decoy Therapeutics Inc. is trading 6.5% up today as it rebounds from a dilution-driven selloff

Decoy Therapeutics Inc. is trading at $6.83 (+6.47%) in pre-market as the stock extends a recovery from its June 16 dilution-related decline. • The stock was...

🟢 Decoy Therapeutics Inc. is trading 10.2% up today as it rebounds from a dilution-driven selloff

Decoy Therapeutics Inc. is trading 10.2% up today at $6.48, reversing a portion of yesterday’s losses tied to dilution concerns from a resale filing. • The...

🔴 Decoy Therapeutics Inc. is trading 5.7% down today on 60% dilution risk from share resale filing

Decoy Therapeutics Inc. is trading 5.7% down today at $5.75 after disclosing a share resale filing that raised significant dilution concerns. • The company...

Decoy Therapeutics files for share resale, facing 60% dilution risk

Decoy Therapeutics files for share resale, facing 60% dilution risk

Decoy Therapeutics filed for an offering of up to 808,000 common shares by selling stockholders on June 15, 2026. This follows a June 12 S-1 filing registering...